Violations Uncovered At GSK, Pfizer Chinese Plants
This article was originally published in Scrip
Executive Summary
Two recently released inspection results by western pharmaceutical regulatory authorities have put GlaxoSmithKline PLC and Pfizer Inc. in the spotlight after both multinationals ran into manufacturing problems in China.